A Three-Dimensional Culture Model Based on the Self-Assembling Peptide Sciobio-II for Drug Sensitivity Testing in Non-Small Cell Lung Cancer

Preclinical drug screening for non-small cell lung cancer (NSCLC) is limited by the inadequate recapitulation of the tumor microenvironment in conventional two-dimensional (2D) culture systems. Here, using PC-9 cells as a proof of concept, we constructed a three-dimensional (3D) cell culture platform based on self-assembling peptides (SAPs) Sciobio-II and evaluated its utility for NSCLC drug sensitivity testing. Structural and mechanical characterization indicates that Sciobio-II self-assembles upon ionic triggering into an ordered, highly interconnected nanofibrous scaffold with long-term stability and hydrogel mechanics. PC-9 cells spontaneously formed spheroids of 50–150 μm in diameter within this 3D system and maintained high proliferative activity for at least 14 days. Drug sensitivity testing to 17 antitumor drugs demonstrated that the 3D culture system exhibits a clear dose-dependent response while yielding quantifiable and comparable values of the area under the curve (AUC), thereby mitigating the evaluation bias associated with the absence of an extracellular matrix (ECM) barrier in 2D culture. This proof-of-concept platform provides a promising in vitro tool that reconstructs tumor ECM structural features for preclinical drug screening and candidate prioritization in NSCLC.

Authors

Institutions

Publication Details

Journal
Gels
Published
2026-11-19
DOI
https://doi.org/10.3390/gels12111054
Primary Topic
Supramolecular Self-Assembly in Materials
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Three-Dimensional Culture Model Based on the Self-Assembling Peptide Sciobio-II for Drug Sensitivity Testing in Non-Small Cell Lung Cancer

Zhongli Luo, Xinyue Zhang, Yu Gao, Jiawei Zhao et al.
Gels
Supramolecular Self-Assembly in Materials
article

A Three-Dimensional Culture Model Based on the Self-Assembling Peptide Sciobio-II for Drug Sensitivity Testing in Non-Small Cell Lung Cancer

Zhongli Luo, Xinyue Zhang, Yu Gao, Jiawei Zhao, Di Su
article en

Abstract

Preclinical drug screening for non-small cell lung cancer (NSCLC) is limited by the inadequate recapitulation of the tumor microenvironment in conventional two-dimensional (2D) culture systems. Here, using PC-9 cells as a proof of concept, we constructed a three-dimensional (3D) cell culture platform based on self-assembling peptides (SAPs) Sciobio-II and evaluated its utility for NSCLC drug sensitivity testing. Structural and mechanical characterization indicates that Sciobio-II self-assembles upon ionic triggering into an ordered, highly interconnected nanofibrous scaffold with long-term stability and hydrogel mechanics. PC-9 cells spontaneously formed spheroids of 50–150 μm in diameter within this 3D system and maintained high proliferative activity for at least 14 days. Drug sensitivity testing to 17 antitumor drugs demonstrated that the 3D culture system exhibits a clear dose-dependent response while yielding quantifiable and comparable values of the area under the curve (AUC), thereby mitigating the evaluation bias associated with the absence of an extracellular matrix (ECM) barrier in 2D culture. This proof-of-concept platform provides a promising in vitro tool that reconstructs tumor ECM structural features for preclinical drug screening and candidate prioritization in NSCLC.

GelsVol. 12(11)
Chongqing Medical University (CN)
Supramolecular Self-Assembly in Materials
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon